We came across a bullish thesis on ADMA Biologics, Inc. on Stockmindsweb’s YouTube Channel. In this article, we will summarize the bulls’ thesis on ADMA. ADMA Biologics, Inc.'s share was trading at $17.70 as of January 13th. ADMA’s trailing and forward P/E were 20.58 and 28.99 respectively according to Yahoo Finance.
[caption id="attachment_575380" align="aligncenter" width="750"]ADMA Biologics is positioned as a differentiated biotech company operating in a sector often marked by volatility and long development timelines, yet it...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.